Stocks
Neurotrope (NTRP) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -629.2% | -440.7% | -1 359% | -1 536% | -506.4% | |||
| Changes by years, y/y, % | +189pp | -919pp | +1 359pp | +25.0% | |||||
Neurotrope. EBITDA margin, %
Neurotrope. EBITDA margin, changes, pp
Neurotrope (NTRP) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EBITDA margin, % | ? | -2 177% | -2 439% | -2 855% | -315.9% | -220.7% | -506.4% | |
| Changes by years, y/y, % | -1 711pp | +2 537pp | +1 956pp | |||||
| Changes by quarters, q/q, % | +2 800pp | -262pp | -415pp | +2 539pp | +95pp | |||
